Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:4 Issue:4 Number:31 ISSN#:2564-2537
ACE Report #7627
Ace Report Cover General Orthopaedics

AAOS 2015: Sublingual sufentanil advantageous over IV morphine for pain after TKA/THA

How to Cite

OrthoEvidence. AAOS 2015: Sublingual sufentanil advantageous over IV morphine for pain after TKA/THA. ACE Report. 2015;4(4):31. Available from: https://myorthoevidence.com/AceReport/Report/7627

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Sufentanil Sublingual Tablet System vs. Intravenous Patient-controlled Morphine for Hip/Knee Arthroplasty Pain

Contributing Authors: M Jove DW Griffin PP Palmer

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


591 patients scheduled to undergo major orthopedic surgery were randomized to receive either sublingual sufentanil or intravenous patient-controlled morphine for postoperative analgesia. This was done to assess the onset of action of a sufentanil sublingual tablet system compared to that of intravenous patient-controlled analgesic morphine. Pain intensity and patient and nurse ease-of-care ratings...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.